These mechanisms collectively lead to the induction of pluripotency-associated transcription factors—including OCT4, SOX2, KLF4, and MYC—thereby reinforcing stemness and plasticity in prostate cancer [87,142]. Here, SOX2 is linked to prostate cancer.